ATE458494T1 - Von der telomerase abgeleitete antigene peptide - Google Patents
Von der telomerase abgeleitete antigene peptideInfo
- Publication number
- ATE458494T1 ATE458494T1 AT03075681T AT03075681T ATE458494T1 AT E458494 T1 ATE458494 T1 AT E458494T1 AT 03075681 T AT03075681 T AT 03075681T AT 03075681 T AT03075681 T AT 03075681T AT E458494 T1 ATE458494 T1 AT E458494T1
- Authority
- AT
- Austria
- Prior art keywords
- telomerase
- antigen peptides
- derived antigen
- derived
- peptides
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001154—Enzymes
- A61K39/001157—Telomerase or TERT [telomerase reverse transcriptase]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO19983141A NO313834B1 (no) | 1998-07-08 | 1998-07-08 | Telomeraseprotein eller -peptider, nukleinsyresekvenser som koder for disse, farmasöytiske sammensetninger inneholdende disseog fremgangsmÕter for Õ fremstille slike farmasöytiskesammensetninger til profylakse mot og behandling av kreft, samt |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE458494T1 true ATE458494T1 (de) | 2010-03-15 |
Family
ID=19902234
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99928238T ATE247484T1 (de) | 1998-07-08 | 1999-06-30 | Von der telomerase abgeleitete antigene peptide |
AT03075681T ATE458494T1 (de) | 1998-07-08 | 1999-06-30 | Von der telomerase abgeleitete antigene peptide |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99928238T ATE247484T1 (de) | 1998-07-08 | 1999-06-30 | Von der telomerase abgeleitete antigene peptide |
Country Status (20)
Country | Link |
---|---|
US (2) | US7030211B1 (de) |
EP (4) | EP2258383B1 (de) |
JP (2) | JP4618657B2 (de) |
CN (1) | CN100376290C (de) |
AR (2) | AR020601A1 (de) |
AT (2) | ATE247484T1 (de) |
AU (1) | AU756094B2 (de) |
CA (2) | CA2336743C (de) |
CY (1) | CY1109978T1 (de) |
CZ (1) | CZ303215B6 (de) |
DE (2) | DE69910580T3 (de) |
DK (2) | DK1362597T3 (de) |
ES (2) | ES2341170T5 (de) |
HK (1) | HK1039068B (de) |
HU (1) | HU230007B1 (de) |
NO (1) | NO313834B1 (de) |
PL (1) | PL203815B1 (de) |
PT (2) | PT1362597E (de) |
TW (1) | TWI261617B (de) |
WO (1) | WO2000002581A1 (de) |
Families Citing this family (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7585622B1 (en) | 1996-10-01 | 2009-09-08 | Geron Corporation | Increasing the proliferative capacity of cells using telomerase reverse transcriptase |
WO1998014592A2 (en) | 1996-10-01 | 1998-04-09 | Geron Corporation | Telomerase reverse transcriptase |
US6475789B1 (en) | 1996-10-01 | 2002-11-05 | University Technology Corporation | Human telomerase catalytic subunit: diagnostic and therapeutic methods |
US7413864B2 (en) | 1997-04-18 | 2008-08-19 | Geron Corporation | Treating cancer using a telomerase vaccine |
US7622549B2 (en) | 1997-04-18 | 2009-11-24 | Geron Corporation | Human telomerase reverse transcriptase polypeptides |
JP2002509716A (ja) | 1998-03-31 | 2002-04-02 | ユニバーシティ テクノロジー コーポレイション | テロメラーゼ抗原に対する免疫応答を惹起するための方法および組成物 |
US7402307B2 (en) | 1998-03-31 | 2008-07-22 | Geron Corporation | Method for identifying and killing cancer cells |
DE69934426T2 (de) * | 1998-10-29 | 2007-10-04 | Whitehead Institute For Biomedical Research, Cambridge | KREBSIMMUNTHERAPIE UND KREBSDIAGNOSE UNTER VERWENDUNG UNIVERSELLER TUMORASSOZIIERTER ANTIGENE EINSCHLIESSLICH hTERT |
AU781376B2 (en) * | 1999-04-09 | 2005-05-19 | Biomira Inc. | Telomerase-specific cancer vaccine |
JP2004527449A (ja) | 2000-02-15 | 2004-09-09 | リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | テロメラーゼ逆転写酵素を用いる癌を治療するための万能ワクチンと方法 |
EP1257284A4 (de) * | 2000-02-15 | 2005-12-21 | Univ California | Ein universelles vakzin und ein verfahren zur behandlung von krebs mit telomerase reverse transkriptase |
FR2812087B1 (fr) * | 2000-07-21 | 2007-05-11 | Inst Nat Sante Rech Med | Procede de criblage de peptides utilisables en immunotherapie |
GB0031430D0 (en) | 2000-12-22 | 2001-02-07 | Norsk Hydro As | Polypeptides |
GB0105238D0 (en) * | 2001-03-02 | 2001-04-18 | Norsk Hydro As | Vaccines |
GB0112342D0 (en) * | 2001-05-21 | 2001-07-11 | Norsk Hydro As | Polypeptides |
ES2527946T3 (es) * | 2003-03-05 | 2015-02-02 | Dendreon Corporation | Composiciones y métodos que emplean polipéptidos de marco de lectura alternativa para el tratamiento de cáncer y enfermedades infecciosas |
EP1748067A1 (de) * | 2005-07-29 | 2007-01-31 | Institut Pasteur | Polynukleotide, die für MHC Klasse I-beschränkte Epitope der hTERT, Analoge und Polyepitope kodieren |
US10767167B2 (en) | 2005-07-29 | 2020-09-08 | Institut Pasteur | Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes |
AU2007215501A1 (en) * | 2006-01-19 | 2007-08-23 | The Regents Of The University Of California | Human telomerase reverse transcriptase peptides |
US9732131B2 (en) | 2006-02-27 | 2017-08-15 | Calviri, Inc. | Identification and use of novopeptides for the treatment of cancer |
WO2008010010A1 (en) * | 2006-07-12 | 2008-01-24 | Vaxon Biotech | Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy |
EP1887084A1 (de) * | 2006-08-10 | 2008-02-13 | International Investment and Patents SA | Plasmide mit immunologischer Wirkung |
JP5207354B2 (ja) * | 2008-03-12 | 2013-06-12 | 独立行政法人産業技術総合研究所 | 転写抑制ペプチド及びその遺伝子 |
HUE030984T2 (en) * | 2008-06-16 | 2017-06-28 | Mediolanum Farm S P A | Antitumor immunotherapy |
WO2010037395A2 (en) * | 2008-10-01 | 2010-04-08 | Dako Denmark A/S | Mhc multimers in cancer vaccines and immune monitoring |
GB0821616D0 (en) | 2008-11-26 | 2008-12-31 | Lytix Biopharma As | Compounds |
CN105106934A (zh) | 2009-11-10 | 2015-12-02 | 急速制药公司 | 用于抑制细胞粘附至rgd结合位点或引导诊断剂或治疗剂至rgd结合位点的组合物和方法 |
US11673914B2 (en) | 2009-11-10 | 2023-06-13 | Allegro Pharmaceuticals, LLC | Peptide therapies for reduction of macular thickening |
EP2536830B1 (de) * | 2010-02-16 | 2019-07-17 | Ultimovacs AS | Polypeptide |
FR2960542B1 (fr) | 2010-05-27 | 2012-08-17 | Esther Suzy Arlette Fellous | Peptide en tant que medicament, en particulier pour le traitement du cancer |
EP2707036A4 (de) | 2011-05-09 | 2015-03-18 | Allegro Pharmaceuticals Inc | Integrinrezeptorantagonisten und verfahren zu ihrer verwendung |
KR20150014483A (ko) | 2012-05-11 | 2015-02-06 | 주식회사 카엘젬백스 | 항염증 활성을 갖는 펩티드 및 이를 포함하는 조성물 |
CN104507489B (zh) * | 2012-05-11 | 2016-07-13 | 杰姆维克斯&凯尔有限公司 | 用于预防和治疗类风湿性关节炎的组合物 |
EP3333180B1 (de) * | 2012-05-11 | 2019-08-21 | KAEL-GemVax Co.,Ltd | Antientzündliche peptide und zusammensetzungen die diese enthaltend |
WO2014010971A1 (ko) * | 2012-07-11 | 2014-01-16 | 주식회사 카엘젬백스 | 세포 투과성 펩티드, 그를 포함한 컨쥬게이트 및 그를 포함한 조성물 |
US20150125438A1 (en) * | 2012-07-20 | 2015-05-07 | Sang Jae Kim | Anti-Inflammatory Peptides and Composition Comprising the Same |
KR102201430B1 (ko) * | 2012-09-19 | 2021-01-12 | 주식회사 젬백스앤카엘 | 세포 투과성 펩티드, 그를 포함한 컨쥬게이트 및 그를 포함한 조성물 |
TWI616530B (zh) * | 2012-09-19 | 2018-03-01 | 傑姆維克斯&凱爾有限公司 | 穿膜胜肽以及包含該胜肽之共軛物及組成物(一) |
KR102038487B1 (ko) | 2012-09-19 | 2019-10-30 | 주식회사 젬백스앤카엘 | 텔로머라제 펩티드를 포함하는 항균 또는 항진균용 조성물 |
CN107312759A (zh) * | 2012-09-19 | 2017-11-03 | 珍白斯凯尔有限公司 | 细胞穿透肽、包含该肽的缀合物、及包含该缀合物的组合物 |
EP3736282B1 (de) | 2012-09-19 | 2023-06-21 | Gemvax & Kael Co., Ltd. | Zellpenertrierendes peptid, konjugat damit und zusammensetzung mit dem konjugat |
KR102166542B1 (ko) | 2012-09-28 | 2020-10-16 | 주식회사 젬백스앤카엘 | 줄기세포 검출을 위한 텔로머라제 유래 펩티드 및 조영물질의 컨쥬게이트 및 이를 포함하는 조영제 |
CN102875657B (zh) * | 2012-10-22 | 2014-04-09 | 南京工业大学 | 一种制备端粒酶多肽疫苗的方法 |
KR102106756B1 (ko) | 2012-12-13 | 2020-05-06 | 주식회사 젬백스앤카엘 | 자외선에 의한 피부 손상 예방 또는 치료용 조성물 |
KR102093093B1 (ko) | 2012-12-13 | 2020-03-25 | 주식회사 젬백스앤카엘 | 피부 노화 개선용 조성물 |
ES2716870T3 (es) * | 2013-04-19 | 2019-06-17 | Gemvax & Kael Co Ltd | Composición para el tratamiento y prevención de lesión isquémica |
KR102275912B1 (ko) * | 2013-05-03 | 2021-07-12 | 주식회사 젬백스앤카엘 | Hsp 발현 억제 펩티드 및 이를 포함하는 조성물 |
US10383926B2 (en) | 2013-06-07 | 2019-08-20 | Gemvax & Kael Co., Ltd. | Biological markers useful in cancer immunotherapy |
ES2808076T3 (es) * | 2013-06-21 | 2021-02-25 | Gemvax & Kael Co Ltd | Regulador de la secreción hormonal, composición que lo contiene y procedimiento para controlar la secreción hormonal mediante su uso |
WO2015005723A1 (ko) * | 2013-07-12 | 2015-01-15 | 주식회사 카엘젬백스 | 세포 투과성 펩티드 및 이를 포함하는 컨쥬게이트 |
WO2015023132A1 (ko) * | 2013-08-14 | 2015-02-19 | 주식회사 카엘젬백스 | 다발성 경화증 치료 및 예방용 조성물 |
GB201315946D0 (en) * | 2013-09-06 | 2013-10-23 | Immune Targeting Systems Its Ltd | Oncology vaccine |
CN110755599A (zh) * | 2013-10-23 | 2020-02-07 | 珍白斯凯尔有限公司 | 用于治疗和预防良性前列腺增生的组合物 |
EP3072519B1 (de) * | 2013-11-22 | 2020-08-19 | Gemvax & Kael Co., Ltd. | Peptid mit angiogenesehemmender wirkung und zusammensetzung damit |
KR102106757B1 (ko) * | 2013-11-29 | 2020-05-06 | 주식회사 젬백스앤카엘 | 난소 동결 보존용 펩티드 및 이를 포함하는 조성물 |
EP3085380B1 (de) * | 2013-12-17 | 2020-06-17 | Gemvax & Kael Co., Ltd. | Zusammensetzung zur behandlung von prostatakrebs |
KR102166549B1 (ko) | 2014-01-10 | 2020-10-16 | 주식회사 젬백스앤카엘 | 혈뇌장벽 투과성 펩티드 및 이를 포함하는 컨쥬게이트 |
KR101503341B1 (ko) * | 2014-03-12 | 2015-03-18 | 국립암센터 | 자가암항원 특이적 cd8+ t 세포의 분리 및 증식방법 |
US9937240B2 (en) | 2014-04-11 | 2018-04-10 | Gemvax & Kael Co., Ltd. | Peptide having fibrosis inhibitory activity and composition containing same |
JP6466971B2 (ja) | 2014-04-30 | 2019-02-06 | ジェムバックス アンド カエル カンパニー,リミティド | 臓器、組織又は細胞移植用組成物、キット及び移植方法 |
WO2015170790A1 (ko) * | 2014-05-09 | 2015-11-12 | 주식회사 카엘젬백스 | 허혈성 손상 치료 및 예방용 조성물 |
CN104031120B (zh) * | 2014-05-29 | 2016-08-24 | 王凤羽 | 一种治疗癌症的肽变体及其应用 |
KR102166543B1 (ko) | 2014-06-02 | 2020-10-16 | 주식회사 젬백스앤카엘 | 켈로이드 억제용 조성물 및 그 억제 방법 |
KR102397510B1 (ko) * | 2014-12-23 | 2022-05-13 | 주식회사 젬백스앤카엘 | 난소 기능 보존용 펩티드 및 이를 포함하는 조성물 |
KR102413243B1 (ko) * | 2014-12-23 | 2022-06-27 | 주식회사 젬백스앤카엘 | 안질환 치료 펩티드 및 이를 포함하는 안질환 치료용 조성물 |
KR102636129B1 (ko) | 2015-02-27 | 2024-02-14 | 주식회사 젬백스앤카엘 | 청력 손상 방어용 펩타이드 및 이를 포함하는 조성물 |
EP3305802B1 (de) | 2015-05-26 | 2021-05-12 | Gemvax & Kael Co., Ltd. | Anti-inflammatorische, anti-fibrotische und wundheilende octapeptide und deren zusammensetzungen |
KR102638286B1 (ko) * | 2015-07-02 | 2024-02-20 | 주식회사 젬백스앤카엘 | 항바이러스 활성 효능을 가지는 펩티드 및 이를 포함하는 조성물 |
KR20170054310A (ko) * | 2015-11-09 | 2017-05-17 | 주식회사 젬백스앤카엘 | 텔로머라제 유래 펩티드를 포함하는 수지상세포 치료제 및 면역 치료제, 및 이를 사용하는 치료방법 |
KR20180123512A (ko) | 2016-04-07 | 2018-11-16 | 주식회사 젬백스앤카엘 | 텔로머라제 활성 증가 및 텔로미어 연장 효능을 가지는 펩티드 및 이를 포함하는 조성물 |
CN110392696B (zh) | 2017-01-06 | 2020-09-11 | 优特力克斯有限公司 | 抗-人4-1bb抗体及其应用 |
US11771749B2 (en) | 2017-02-03 | 2023-10-03 | The Medical College Of Wisconsin, Inc. | KRAS peptide vaccine compositions and method of use |
JP2020522479A (ja) | 2017-06-02 | 2020-07-30 | アリゾナ ボード オブ リージェンツ オン ビハーフ オブ アリゾナ ステート ユニバーシティ | 個別化された癌ワクチンを作製する方法 |
US20200209241A1 (en) | 2017-09-15 | 2020-07-02 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods of classifying response to immunotherapy for cancer |
WO2020002650A1 (en) | 2018-06-29 | 2020-01-02 | Targovax Asa | A formulation |
WO2021067550A1 (en) | 2019-10-02 | 2021-04-08 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods and compositions for identifying neoantigens for use in treating and preventing cancer |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9103974D0 (en) | 1991-02-26 | 1991-04-10 | Norsk Hydro As | Therapeutically useful peptides or peptide fragments |
EP0765386B1 (de) | 1994-06-14 | 2014-12-10 | The Board Of Trustees Of The Leland Stanford Junior University | Methode zur in vivo aktivierung von t-zellen mit antigen inkubierten dendritischen zellen |
US5968506A (en) | 1995-08-04 | 1999-10-19 | Geron Corporation | Purified telomerase |
ES2184990T3 (es) * | 1996-02-12 | 2003-04-16 | Ml Lab Plc | Nuevos metodos de vacunacion y vacunas para los mismos que comprenden un acido nucleico que codifica un primer epitope y un peptido que contiene un segundo epitope. |
BR9708387A (pt) | 1996-03-28 | 2000-01-04 | Genitrix Llc | Processo para vacinação de um mamìfero a um antìgeno selecionado, células patogênica e hospedeira, composição de vacina, ácido nucleico, e, opsonina engenheirada. |
US5770422A (en) | 1996-07-08 | 1998-06-23 | The Regents Of The University Of California | Human telomerase |
DE69733255T2 (de) * | 1996-07-08 | 2006-01-19 | Vivoxid Oy | Bioabbaubares material mit hoher schlagzähigkeit |
WO1998014592A2 (en) * | 1996-10-01 | 1998-04-09 | Geron Corporation | Telomerase reverse transcriptase |
US7390891B1 (en) | 1996-11-15 | 2008-06-24 | Amgen Inc. | Polynucleotides encoding a telomerase component TP2 |
JP2002509716A (ja) | 1998-03-31 | 2002-04-02 | ユニバーシティ テクノロジー コーポレイション | テロメラーゼ抗原に対する免疫応答を惹起するための方法および組成物 |
US6337200B1 (en) | 1998-03-31 | 2002-01-08 | Geron Corporation | Human telomerase catalytic subunit variants |
-
1990
- 1990-06-30 US US09/743,281 patent/US7030211B1/en not_active Expired - Lifetime
-
1998
- 1998-07-08 NO NO19983141A patent/NO313834B1/no not_active IP Right Cessation
-
1999
- 1999-06-30 DE DE1999610580 patent/DE69910580T3/de not_active Expired - Lifetime
- 1999-06-30 ES ES03075681.1T patent/ES2341170T5/es not_active Expired - Lifetime
- 1999-06-30 PL PL345541A patent/PL203815B1/pl unknown
- 1999-06-30 CN CNB998099546A patent/CN100376290C/zh not_active Expired - Lifetime
- 1999-06-30 HU HU0104889A patent/HU230007B1/hu unknown
- 1999-06-30 CA CA 2336743 patent/CA2336743C/en not_active Expired - Lifetime
- 1999-06-30 EP EP10154215.7A patent/EP2258383B1/de not_active Expired - Lifetime
- 1999-06-30 WO PCT/NO1999/000220 patent/WO2000002581A1/en active IP Right Grant
- 1999-06-30 CA CA 2748996 patent/CA2748996A1/en not_active Abandoned
- 1999-06-30 EP EP20030075681 patent/EP1362597B2/de not_active Expired - Lifetime
- 1999-06-30 EP EP99928238A patent/EP1093381B2/de not_active Expired - Lifetime
- 1999-06-30 PT PT03075681T patent/PT1362597E/pt unknown
- 1999-06-30 DK DK03075681T patent/DK1362597T3/da active
- 1999-06-30 ES ES99928238T patent/ES2200526T5/es not_active Expired - Lifetime
- 1999-06-30 JP JP2000558840A patent/JP4618657B2/ja not_active Expired - Lifetime
- 1999-06-30 PT PT99928238T patent/PT1093381E/pt unknown
- 1999-06-30 AT AT99928238T patent/ATE247484T1/de active
- 1999-06-30 AT AT03075681T patent/ATE458494T1/de active
- 1999-06-30 DK DK99928238T patent/DK1093381T4/da active
- 1999-06-30 AU AU45340/99A patent/AU756094B2/en not_active Expired
- 1999-06-30 CZ CZ20010037A patent/CZ303215B6/cs not_active IP Right Cessation
- 1999-06-30 DE DE69942072T patent/DE69942072D1/de not_active Expired - Lifetime
- 1999-06-30 EP EP10183808.4A patent/EP2316476B1/de not_active Expired - Lifetime
- 1999-07-12 AR ARP990103374 patent/AR020601A1/es active IP Right Grant
- 1999-09-03 TW TW88115173A patent/TWI261617B/zh not_active IP Right Cessation
-
2002
- 2002-01-25 HK HK02100577.9A patent/HK1039068B/zh not_active IP Right Cessation
-
2006
- 2006-01-17 US US11/332,378 patent/US7794723B2/en not_active Expired - Fee Related
-
2010
- 2010-04-23 CY CY101100364T patent/CY1109978T1/el unknown
- 2010-07-15 AR ARP100102596 patent/AR077576A2/es unknown
- 2010-08-06 JP JP2010177870A patent/JP5491315B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE458494T1 (de) | Von der telomerase abgeleitete antigene peptide | |
ATE317854T1 (de) | Hepatitis c inhibitor peptide | |
NO982097L (no) | Peptider | |
NO982098L (no) | Peptider | |
NO2010013I2 (no) | Rekombinant FSH-CTP | |
DK1042359T3 (da) | k-Opioidreceptorpeptider | |
CY2005008I1 (el) | Αντισωματα αντι - vegf | |
DE69839603D1 (de) | Zierenden proteins | |
NO20002990L (no) | Nytt overflateprotein | |
DE69427370T2 (de) | Neue integrinbindende peptide | |
DE4393381T1 (de) | Peptide | |
DE69931010D1 (de) | Peptide mit osteogener Aktivität | |
FI970168A0 (fi) | Peptidejä | |
DE60042130D1 (de) | Neue antigene hev-peptide und methoden | |
ID26730A (id) | Induksi protein-protein dan peptida-peptida antibiotik oleh lait/scd14-protein | |
DE69427363T2 (de) | Plättchenaggregationsinhibierende peptide | |
EP1136555A4 (de) | Tumorantigen protein art-1 und tumorantigen peptide davon | |
NO20005547D0 (no) | Myelinbasiske proteinpeptider og anvendelser derav | |
GB0115428D0 (en) | Antibodies, peptides, analogs and uses thereof | |
NO20012283D0 (no) | Koblede peptider | |
DE69638206D1 (de) | Antineoplastische Peptide | |
EP0984065A4 (de) | Modifiziertes, von treponema palladium stammendes proteinantigen. | |
DK1017798T3 (da) | Lunasinpeptider | |
NO20000976D0 (no) | Peptider | |
NO996412D0 (no) | Antigene peptider |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1362597 Country of ref document: EP |